Richard L. Gabriel, Director at Precision Therapeutics Inc. (AIPT), bought 1,000 shares at $0.89 ($890) on 2018-11-20, disclosed to the SEC on 2018-11-23.
Open-market purchase of $890 AIPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| POAI | BUY | 2019-09-06 | $920 | — | Filing → |
| POAI | BUY | 2019-08-26 | $2K | — | Filing → |
| AIPT | BUY | 2018-12-12 | $1K | — | Filing → |